Translational Cancer Research

Papers
(The TQCC of Translational Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma78
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study69
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report42
Molecular basis of heterogeneity in small cell lung cancer36
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study28
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial27
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer24
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study24
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes21
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors21
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?20
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking20
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy20
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation20
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study19
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis19
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma19
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma19
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes19
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy18
Treatment of immune checkpoint inhibitor-related colitis: a narrative review18
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis18
Development and validation of a clinical diagnostic model for surgical site infection after surgery in patients with gastric cancer17
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review17
A prediction model of gastric cancer based on M2-like tumor-associated macrophage infiltration verified by immunohistochemistry16
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma16
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases16
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer15
CLCN3 in mediating the proliferation of human ovarian cancer cells15
Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer15
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer15
Targeted next-generation sequencing reveals genomic differences between male and female breast cancer15
Results of the feasibility study of clinical trials of the new cancer treatment technology Karanahan for patients with advanced breast cancer14
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases14
The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma14
Diagnostic performances of skin cancers using intensity- and gradient-based features with optical coherence tomography: a pilot study14
Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma14
Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-β1/Smads14
Expression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes: implications for immune modulation and clinical outcomes14
Knockdown of TRIM35 suppresses cell proliferation and metastasis by modulating the PPAR signalling pathway in papillary thyroid cancer cells13
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review13
Combining Bulk RNA-seq and scRNA-seq data to identify RNA m5C methyltransferases NSUN1: a rising star as a biomarker for cancer diagnosis, prognosis and therapy13
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates13
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review13
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance12
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment12
Identification and validation of tumor microenvironment remodeling markers associated with prognosis in differentiated thyroid cancer12
Prognostic significance of lymph node-related indices and a novel nomogram for rectal cancer patients with synchronous liver metastases after the preoperative chemoradiotherapy: a population-based stu12
PTPMT1 inhibition induces apoptosis and growth arrest of human SCLC cells by disrupting mitochondrial metabolism12
Identification of prognostic immune-related genes and evaluation of chemotherapy and immunotherapy responses in pancreatic cancer12
Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study12
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer12
Effects of p-cresol, a uremic toxin, on cancer cells12
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer11
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning11
Clinicopathological characteristics and long-term prognosis of duodenal signet ring cell carcinoma: a SEER-based analysis11
Three-dimensional model to simulate esophagectomy in patients with a mediastinal vascular anomaly: to see is to believe11
A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma11
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients11
TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation11
Interpretable machine learning prediction of 1-year overall survival in pancreatic cancer patients aged 65 years and older11
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study11
The role of targeted therapy in the management of colorectal cancer liver metastases: a systematic review and meta-analysis11
Utilization of intraoperative indocyanine green fluorescence imaging to identify vascular anatomy in severe pleural adhesions in uniportal video-assisted thoracoscopic surgery: a case report11
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn11
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER database11
Oncologic and obstetric outcomes of a novel nerve-sparing radical trachelectomy while preserving the uterine branches of the pelvic nerves11
Development and validation of nomogram-based models for personalized survival assessment in pediatric hepatoblastoma patients10
The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial10
The value of an integrated multi-omics model in the diagnosis of benign and malignant pulmonary nodules10
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma10
Explainable machine-learning prediction of overall and cancer-specific survival in adult triple-negative breast cancer using SEER: a comparative study of nomograms and random survival forests10
Development and internal validation of a multivariable prognostic prediction model in advanced breast cancer patients based on the SEER database10
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?10
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer10
Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations10
Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma10
OSBPL3 promotes colorectal cancer progression through modulation of TGF-β signaling and immune cell infiltration10
Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma10
Value of ZSCAN9 in the treatment and survival prediction of hepatocellular carcinoma: a bioinformatics study10
Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma10
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER10
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors10
Magnetic resonance imaging-based radiomics analysis: predicting vascular invasion in breast invasive ductal carcinoma using different machine learning models10
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses9
Prognostic implications of a programmed cell death-related long non-coding RNA signature and its relevance to immune features in esophageal carcinoma9
Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma9
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification9
Development of a prognostic nomogram for colorectal cancer with peritoneal metastasis: a SEER database analysis9
Identification of exhausted CD8+ T-cell signatures for prognosis in multiple myeloma by integrated analysis of single-cell and bulk RNA-sequencing9
TRIM47 promotes cell viability, cell cycle progression, metabolic reprogramming, and inhibits apoptosis of glioma via the NF-κB signaling pathway9
Artificial intelligence applications in adaptive radiotherapy—a narrative review9
Undifferentiated embryonic sarcoma of the adult liver with paraneoplastic syndrome: a case report9
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database9
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China9
Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma9
Intratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis9
Construction of a prognostic signature for breast cancer based on genes involved in unsaturated fatty acid biosynthesis9
Role of PDGFA expression in the prognosis of head and neck squamous cell carcinoma: construction of prognostic nomogram and functional mechanism exploration9
Comparison of 5-year survival rates and prognostic factors between adenoid cystic carcinoma and squamous cell carcinoma of the maxillary sinus: a SEER database analysis9
ATP5A1 as a potential prognostic biomarker in clear-cell renal cell carcinoma9
Bridging histopathology, inferred transcriptomics, and immunotherapy response prediction in head and neck cancer9
The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer9
DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway9
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis9
Problems and countermeasures for surgical resection of primary pulmonary artery intimal sarcoma9
The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis9
Targeting the gut microbiota-metabolite-immune axis in cancer immunotherapy: mechanistic interplay, therapeutic strategies, and translational applications-a narrative review9
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer9
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer9
MicroRNA-663a upregulation upon ARID1A depletion promotes the growth and migration of esophageal cancer cells by targeting FKBP89
A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer9
Telomere-related gene risk model for prognosis prediction in colorectal cancer9
IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway9
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria9
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report9
Women’s hormonal health research and care: the times, they are a-changin’8
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma8
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro8
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma8
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy8
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells8
Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China8
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer8
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database8
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinoma8
Association between human epidermal growth factor receptor 2 status, namely low and zero expression, and prognosis in hormone receptor-positive breast cancer: a single-center retrospective study8
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells8
Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes8
Comparison of the short-term outcomes of open and laparoscopic hepatectomy in the treatment of recurrent hepatocellular carcinoma: a single-center retrospective study8
Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling8
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review8
Secretogranin II serves as a potential prognostic biomarker and correlates with the immune microenvironment in pancreatic neuroendocrine tumors8
Survival analysis of gastric malignancy patients: identifying key prognostic factors8
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and met8
A nomogram for predicting overall survival in advanced hepatocellular carcinoma patients receiving radiotherapy combined with targeted therapy: a multicenter retrospective study8
Comprehensive analysis of gene signature linking hypoxia and lactylation for predicting prognosis and immunotherapy response in patients with gastric cancer8
Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR8
Prognostic significance of chemotherapy response score in predicting outcomes for high-grade serous ovarian carcinoma patients undergoing neoadjuvant chemotherapy8
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma8
Risk factors, prognostic factors and nomograms for distant metastasis in colorectal neuroendocrine neoplasms: a SEER-based study8
Uterine intravascular leiomyomatosis involves the heart: a case report and literature review8
ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cel8
Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy8
Key genes and pathway differences between serrated polyps and conventional adenomas: insights from multi-omics8
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response8
Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer8
Catheter-directed thrombectomy combined with angioplasty and stent implantation for superior vena cava syndrome: a case report8
An immune-related miRNA signature predicts the prognosis in nasopharyngeal carcinoma8
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges8
KIF18A and CDK1 as combined therapeutic targets in cervical and endometrial carcinomas: based on bioinformatics analysis and in vitro experiments8
Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment8
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer7
Development and validation of a pathomics model to predict SOX11 expression and prognosis in hepatocellular carcinoma7
Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma7
Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer7
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection7
Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma7
PM2.5 promotes non-small cell lung cancer tumorigenesis by miR-21-5p targeting PDE4DIP accumulated7
Development and validation of a predictive model for perioperative venous thromboembolism in colorectal cancer patients based on D-dimer combined with fibrinogen levels7
Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database7
Exosomal microRNAs in lung cancer: a narrative review7
GNAL-driven calcium signaling reshapes the spatiotemporal immune landscape in ER+ breast cancer: causal insights and prognostic implications7
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics7
Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients7
Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence7
LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells7
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre7
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer7
Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?7
Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis7
The flavonoid astragalin induces apoptosis in lung adenocarcinoma and correlates with a prognostic cell cycle gene signature associated with PANoptosis7
Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH17
Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells7
FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells7
Oncologic outcome of breast reconstruction after mastectomy in breast cancer: a systematic review and meta-analysis7
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes7
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications7
New model for remote symptom management and self-care of cancer patients based on digital health platforms: a narrative review7
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma7
B7-H3 promotes proliferation and migration of lung cancer cells by modulating PI3K/AKT pathway via ENO1 activity7
Efficacy of transarterial chemoembolization combined with PD-1 versus PD-L1 inhibitors in mass-forming intrahepatic cholangiocarcinoma: a multicenter retrospective study7
KCNK9 could be a prognostic biomarker in uterine corpus endometrial carcinoma7
Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene7
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis7
Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma7
Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA7
Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database7
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta7
LINC02081 as an oncogene promotes cell proliferation and G2/M cycle through p53 signaling pathway in lung adenocarcinoma7
Study on the value of multi-dimensional conformal radiotherapy and functional imaging in tumor bioimaging7
Efficacy and safety of combined RANKL and PD-1 inhibitors in bone metastases: a retrospective study7
Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study7
Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p7
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma7
Identification of hub genes and key modules in laryngeal squamous cell carcinoma7
Effect and mechanism of auranofin on extrusion and migration of breast cancer cells7
Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines7
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing d6
Identification and validation of an immune-related programmed cell death signature for predicting prognosis and immunotherapy in large-scale multicenter cohorts for lung adenocarcinoma6
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune mi6
A pneumolysin mutant (ΔA146 ply) induces pyroptosis in triple-negative and HER2-positive breast cancer cells via the Caspase-1/GSDME pathway: a potential antibody-drug conjugate payload6
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors6
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation6
High-sensitivity modified Glasgow prognostic score (HS-mGPS) is a prognostic biomarker for small duct-type intrahepatic cholangiocarcinoma—a retrospective cohort study6
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinoma6
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non-small cell lung cancer6
Preoperative peripheral blood lymphocyte subsets integrated with geriatric nutritional risk index for prognostic assessment in elderly colorectal carcinoma patients6
A novel prognostic model based on endoplasmic reticulum stress-associated E3 ligases and deubiquitinating enzymes in hepatocellular carcinoma6
Personalized survival prediction in pediatric glioblastoma using a machine learning-powered web tool6
Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer6
Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma6
Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma6
Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies—a narrative review6
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancer6
Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis6
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study6
A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer6
A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma6
Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report6
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes6
Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma6
Beyond survival: the role of quality of life in modern urothelial cancer therapy6
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?6
Investigating the material basis and molecular mechanisms of Oldenlandia diffusa in the treatment of papillary thyroid carcinoma: a network pharmacology and experimental study6
Molecular mechanisms of circular RNA in breast cancer: a narrative review6
Pulmonary metastasis risk and overall survival score in choriocarcinoma: a novel nomogram-based risk assessment system6
The influence of CXCL9 on M2 macrophages in lung cancer development6
The impact of the location, incidence and distribution of lung metastases in primary colorectal and renal cell cancer patients on prognosis: a retrospective observational study6
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men6
Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis6
Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma6
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death6
Comparable prognosis of early gastric cancer between intestinal type and diffuse type in patients of age 75 and older: a SEER-based cohort study6
Integrating WGCNA and machine learning algorithm to identify ACSM5 as a prognostic biomarker and therapeutic target for predicting immunotherapy efficacy in non-small cell lung cancer6
UBA6 serves as a prognostic biomarker and promotes tumor progression in pancreatic ductal adenocarcinoma6
Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis6
The prognostic value of immune escape-related genes in lung adenocarcinoma6
Radiation induced lung injury (RILI) after postoperative intensity modulated proton therapy (IMPT) in a patient with stage III locally advanced lung adenocarcinoma: a case report6
Diagnosis and multimodality treatment of primary malignant tracheal tumors6
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEER6
CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma6
Exploring the lactate-metabolism related characteristics during the development of medulloblastoma through single-cell and bulk RNA-seq6
Individual and combined effects of marital status, household income, and residence on cancer management and survival in primary bone cancer: a SEER-based retrospective cohort study6
Molecular characterization and prognostic modeling of liquid- liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis6
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment6
Retraction: H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition6
KLF15-POU3F4 axis activates PI3K/AKT signaling to promote glioma progression6
Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model6
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes6
0.48954200744629